AlCl3-Assisted Ring Opening of Chiral Oxaziridines
7.38 (m, 7 H), 4.74 (s, 1 H), 3.81 (s, 3 H), 3.72 (s, 3 H), 3.18-
3.47 (m, 3 H). 13C NMR (CDCl3) δ 172.3, 158.2, 142.0, 129.0,
128.7, 128.0, 127.1, 126.0, 114.4, 78.5, 68.3, 57.8, 52.3, 33.0.
MS (EI) m/z (relative intensity %) 313 (M+•, 0.9), 298 (1.2),
282 (2.2), 254 (1.4), 163 (3.9), 151 (70.1), 135 (100), 120 (13.1),
107 (14.9), 92 (9.3), 77 (11.8), 64 (7.9), 51 (4.2). HRMALDI:
calcd for C18H20NO4 (M + H)+, 314.13923; found 314.13926.
Oxaziridine 5a: Pale yellow oil (53.2 mg, 0.17 mmol; 3%).
[R]20D -23.5 (c 1.0, CHCl3). TLC (Et2O/n-hexane 60:40, v/v) Rf
0.63. FT-IR (neat) 3029, 2957, 2833, 1751, 1618, 1517, 1250,
1168 cm-1. 1H NMR (CDCl3) δ 7.68 (d, 2 H, J ) 8.1 Hz), 6.70-
7.39 (m, 7 H), 4.72 (s, 1 H), 3.79 (s, 3 H), 3.70 (s, 3 H), 3.19-
3.47 (m, 3 H). 13C NMR (CDCl3) δ 172.3, 159.0, 142.0, 128.8,
128.5, 128.0, 127.3, 126.3, 114.8, 80.1, 69.0, 57.9, 52.7, 32.1.
MS (EI) m/z (relative intensity %) 313 (M+•, 1.2), 298 (1.2),
282 (1.9), 254 (1.1), 163 (4.9), 151 (72.0), 135 (100), 120 (11.3),
107 (10.7), 92 (10.1), 77 (12.2), 64 (7.2), 51 (3.9). HRMALDI:
calcd for C18H20NO4 (M + H)+, 314.13923; found 314.13920.
Oxaziridine 2b: Pale yellow oil (1.124 g; 4.03 mmol; 70%).
[R]20D -49.2 (c 1.0, CHCl3). TLC (Et2O/n-hexane 60:40, v/v) Rf
0.79. FT-IR (neat) 3170, 2958, 2770, 1752, 1621, 1512, 1235,
diastereomers; 2.2 mmol) dissolved in dry ethanol-free meth-
ylene chloride (10 mL), AlCl3 (0.59 g, 4.4 mmol) was added.
After 5 min at rt, a solution of the free O-benzylhydroxylamine
(0.6 g; 2.2 mmol) in dry ethanol-free methylene chloride (10
mL) was added, and the resulting mixture was refluxed under
magnetic stirring for 25 min. After this time, TLC (Et2O/n-
hexane 60:40, v/v) showed the reaction to be complete. The
solution was cooled at rt, then treated with a 1 N HCl aqueous
solution (pH ) 3). The aqueous phase was separated, and the
organic layer, after drying on MgSO4, was filtered and
evaporated to dryness. The residue was treated with a dry
ethanol-free methylene chloride (10 mL) solution containing
1H-imidazole (0.15 g, 2.2 mmol) and triisopropylsilyl triflate
(TIPSOTf; 0.52 mL, 2.2 mmol) under magnetic stirring at rt.
Reaction was complete in 3 h, as checked by TLC (Et2O/n-
hexane 60:40, v/v). The organic solvent was removed under
reduced pressure conditions, and the solid residue was dis-
solved in a 5% NaHCO3 aqueous solution (5 mL). The aqueous
phase was extracted with AcOEt (3 × 5 mL), and the collected
organic layers were washed once with a 5% KHSO4 aqueous
solution (5 mL) and once with brine (5 mL). After drying on
MgSO4, the solvent was removed under reduced pressure
conditions to give a pale yellow crude material, which was
chromatographed to afford the title compounds in 92-94%
overall yields.
1
1170 cm-1. H NMR (CDCl3) δ 7.38 (d, 2 H, J ) 8.1 Hz), 7.04
(d, 2 H, J ) 8.1 Hz), 4.51 (s, 1 H), 3.78 (s, 3 H), 3.76 (s, 3 H),
3.23 (dd, 1 H, J ) 9.2 Hz, J ) 6.3 Hz), 1.61-1.82 (m, 3 H),
0.87 (d, 6 H, J ) 7.4 Hz). 13C NMR (CDCl3) δ 172.6, 159.3,
130.1, 127.6, 115.0, 79.3, 63.5, 56.0, 51.8, 35.0, 23.1, 22.0. MS
(EI) m/z (relative intensity %) 279 (M+•, 0.1), 223 (14.4), 191
(9.3), 151 (4.5), 135 (100), 107 (8.7), 92 (5.4), 76 (7.2), 64 (13.1),
59 (34.0), 43 (72.3). HRMALDI: calcd for C15H22NO4 (M + H)+,
280.15488; found 280.15484.
N-Hydroxy-O-triisopropylsilyl-r-L-amino Acid Methyl
Ester 21: White powder (0.73 g, 2.07 mmol; 94%), mp 122-
124 °C. [R]20 +22.1 (c 2.0, CHCl3). TLC (Et2O/n-hexane 60:
D
40, v/v) Rf 0.72. FT-IR (KBr) 3350, 3310, 3065, 2870, 2810,
1752, 1554, 1352, 1102 cm-1 1H NMR (CDCl3) δ 7.31-7.36
.
Oxaziridine 3b: Pale yellow oil (0.29 g, 1.04 mmol; 18%).
[R]20D -45.3 (c 1.0, CHCl3). TLC (Et2O/n-hexane 60:40, v/v) Rf
0.77. FT-IR (neat) 3168, 2949, 2771, 1750, 1622, 1518, 1235,
(m, 5 H), 6.11 (d, 1 H, J ) 10.1 Hz), 3.87 (ddd, 1 H, J ) 10.1
Hz, J ) 9.1 Hz, J ) 6.3 Hz), 3.71 (s, 3 H), 3.02 (dd, 1 H, J )
13.5 Hz, J ) 6.3 Hz), 2.89 (dd, 1 H, J ) 13.5 Hz, J ) 9.1 Hz),
1.81 (septet, 3 H, J ) 7.1 Hz), 0.93 (d, 18 H, J ) 7.1 Hz). 13C
NMR (CDCl3) δ 171.9, 140.1, 128.7, 127.1, 125.9, 67.7, 52.3,
33.4, 17.8, 10.2. MS (EI) m/z (relative intensity %) 351 (M+.,
21.9), 336 (21.6), 320 (3.4), 308 (9.8), 292 (10.8), 274 (24.3),
260 (9.7), 194 (8.8), 188 (21.7), 178 (11.2), 173 (7.8), 163 (9.9),
157 (15.7), 91 (100), 77 (87.5), 65 (56.9), 59 (34.9), 51 (45.3),
43 (87.9), 31 (34.0). HRMALDI: calcd for C19H34NO3Si (M +
H)+, 352.23080; found 352.23075.
1
1171 cm-1. H NMR (CDCl3) δ 7.38 (d, 2 H, J ) 8.0), 7.05 (d,
2 H, J ) 8.0), 4.54 (s, 1 H), 3.81 (s, 3 H), 3.75 (s, 3 H), 3.23
(dd, 1 H, J ) 9.2 Hz, J ) 6.2 Hz), 1.61-1.83 (m, 3 H), 0.88 (d,
6 H, J ) 7.4 Hz). 13C NMR (CDCl3) δ 171.9, 159.1, 130.0, 127.5,
114.8, 78.1, 64.3, 57.1, 52.8, 34.8, 23.0, 21.8. MS (EI) m/z
(relative intensity %) 279 (M+•, 0.1), 223 (14.4), 191 (9.8), 151
(7.8), 135 (100), 107 (10.7), 92 (7.4), 76 (7.1), 64 (12.8), 59 (34.3),
43 (70.0). HRMALDI: calcd for C15H22NO4 (M + H)+, 280.15488;
found 280.1548.
N-Hydroxy-O-triisopropylsilyl-r-L-amino Acid Methyl
Ester 22: White powder (0.64 g, 2.024 mmol; 92%), mp 90-
92 °C. [R]20D +18.5 (c 2.0, CHCl3). TLC (Et2O/n-hexane 60:40,
v/v) Rf 0.74. FT-IR (KBr) 3348, 3299, 2875, 2820, 1751, 1550,
Oxaziridine 4b: Pale yellow oil (97.7 mg, 0.35 mmol; 6%).
[R]20D -23.0 (c 1.0, CHCl3). TLC (Et2O/n-hexane 60:40, v/v) Rf
0.76. FT-IR (neat) 3170, 2959, 2770, 1749, 1620, 1510, 1238,
1
1171 cm-1. H NMR (CDCl3) δ 7.36 (d, 2 H, J ) 8.1 Hz), 6.98
1349, 1100 cm-1 1H NMR (CDCl3) δ 6.10 (d, 1 H, J ) 10.4
.
(d, 2 H, J ) 8.1 Hz), 4.62 (s, 1 H), 3.80 (s, 3 H), 3.73 (s, 3 H),
3.19 (dd, 1 H, J ) 9.1 Hz, J ) 6.4 Hz), 1.62-1.81 (m, 3 H),
0.87 (d, 6 H, J ) 7.3 Hz). 13C NMR (CDCl3) δ 172.3, 159.6,
129.8, 127.6, 115.1, 80.1, 65.5, 56.7, 52.3, 35.3, 23.2, 22.1. MS
(EI) m/z (relative intensity %) 279 (M+•, 0.4), 223 (13.4), 191
(10.1), 151 (3.5), 135 (100), 107 (8.9), 92 (8.4), 76 (7.2), 64 (10.1),
59 (34.0), 43 (72.3). HRMALDI: calcd for C15H22NO4 (M + H)+,
280.15488; found 280.15490.
Hz), 3.68 (s, 3 H), 3.40-3.52 (m, 1 H), 1.79 (septet, 3 H, J )
7.2 Hz), 1.53-1.71 (m, 1 H), 1.27-1.36 (m, 2 H), 0.85-0.92
(m, 24 H). 13C NMR (CDCl3) δ 172.2, 65.7, 52.2, 37.8, 23.1,
22.8, 17.8, 10.1. MS (EI) m/z (relative intensity %) 317 (M+•
,
12.2), 302 (10.2), 286 (8.9), 274 (34.2), 260 (12.6), 258 (44.1),
188 (24.0), 173 (28.7), 160 (22.3), 157 (15.8), 144 (11.0), 129
(12.4), 59 (22.1), 57 (100), 43 (87.0), 31 (23.1). HRMALDI: calcd
for C16H36NO3Si (M + H)+, 318.24645; found 318.24640.
Oxaziridine 5b: Pale yellow oil (47.4 mg, 0.17 mmol; 3%).
[R]20D -24.4 (c 1.0, CHCl3). TLC (Et2O/n-hexane 60:40, v/v) Rf
0.75. FT-IR (neat) 3167, 2954, 2772, 1751, 1620, 1518, 1234,
Acknowledgment. This work was supported by
financial grants from Ministero dell’Istruzione, dell’Uni-
versita` e della Ricerca (MIUR).
1
1165 cm-1. H NMR (CDCl3) δ 7.39 (d, 2 H, J ) 8.0 Hz), 6.97
(d, 2 H, J ) 8.0 Hz), 4.60 (s, 1 H), 3.78 (s, 3 H), 3.70 (s, 3 H),
3.16 (dd, 1 H, J ) 9.2 Hz, J ) 6.1 Hz), 1.60-1.83 (m, 3 H),
0.88 (d, 6 H, J ) 7.4 Hz). 13C NMR (CDCl3) δ 171.8, 159.0,
129.5, 127.3, 114.6, 80.4, 64.4, 57.0, 51.9, 34.6, 23.6, 21.7. MS
(EI) m/z (relative intensity %) 279 (M+•, 0.4), 223 (15.9), 191
(11.2), 151 (5.5), 135 (100), 107 (8.9), 92 (10.4), 76 (8.2), 64
(11.8), 59 (32.4), 43 (71.3). HRMALDI: calcd for C15H22NO4
(M + H)+, 280.15488; found 280.15485.
Supporting Information Available: General experimen-
tal methods and detailed descriptions of procedures used for
the synthesis of oxaziridines 18-20 and N-hydroxy-O-triiso-
propylsilyl-R-L-amino acid methyl esters 23-25, spectral
characterization of O-benzylaldoximates 14 and 15, and
elemental analysis of compounds 2a-5a, 2b-5b, 14, 15, and
21-25. This material is available free of charge via the
Synthesis of N-Hydroxy-O-triisopropylsilyl-r-L-amino
Acid Methyl Esters 21 and 22. General Procedure. To a
solution of the appropriate oxaziridine (used as mixture of
JO051890+
J. Org. Chem, Vol. 70, No. 25, 2005 10501